Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$6M+12.0% YoY

Gross Profit

$3M56.8% margin

Operating Income

-$5M-85.0% margin

Net Income

-$5M-83.5% margin

EPS (Diluted)

$-0.20

QoQ Revenue Growth

-3.2%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$44M

Total Liabilities

$20M

Stockholders' Equity

$24M

Cash & Equivalents

$24M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$6M	$5M	+12.0%
Gross Profit	$3M	$4M	-11.0%
Operating Income	-$5M	-$4M	-29.0%
Net Income	-$5M	-$4M	-27.0%

Revenue Segments

Biologics And Drug Delivery

$3M41%

Functional Neurosurgery Navigation and Therapy

$2M23%

Functional Neurosurgery Navigation and Therapy - Disposable Products

$2M22%

Biologics And Drug Delivery - Disposable Products

$455,0005%

Capital Equipment And Software

$357,0004%

Capital Equipment And Software - Services

$276,0003%

Capital Equipment And Software - Systems and Software Products

$81,0001%

Functional Neurosurgery Navigation and Therapy - Services

$44,0001%